Difference between revisions of "Non-invasive breast carcinoma"

Jump to navigation Jump to search
(format, refs)
(+ADH, more on lobular hyperplasia, re-organize)
Line 6: Line 6:


Invasive breast cancer is dealt with in the article ''[[invasive breast cancer]]''.
Invasive breast cancer is dealt with in the article ''[[invasive breast cancer]]''.
=Ductal neoplasia=
This category includes:
#Atypical ductal hyperplasia (ADH).
#Ductal carcinoma in situ (DCIS).
*These entities (ADH, DCIS) have some over lap.
*The difference ''is'':
*#The degree of nuclear atypia; high grade is DCIS.
*#The extent; small lesions are ADH, large lesions (low-grade) DCIS.


==Ductal carcinoma in situ==
==Ductal carcinoma in situ==
Line 119: Line 129:
*DCIS - excision (lumpectomy) + radiation.
*DCIS - excision (lumpectomy) + radiation.
*Invasive ductal carcinoma - excision with sentinel lymph node disection<ref>Sentinel Lymph Node Biopsy: What Breast Cancer Patients Need to Know. cancernews.com. URL: [http://www.cancernews.com/data/Article/202.asp http://www.cancernews.com/data/Article/202.asp]. Accessed on: 9 October 2009.</ref> and radiation.
*Invasive ductal carcinoma - excision with sentinel lymph node disection<ref>Sentinel Lymph Node Biopsy: What Breast Cancer Patients Need to Know. cancernews.com. URL: [http://www.cancernews.com/data/Article/202.asp http://www.cancernews.com/data/Article/202.asp]. Accessed on: 9 October 2009.</ref> and radiation.
=Lobular neoplasia=
==Overview==
Includes:
#Atypical lobular hyperplasia (ALH).
#Lobular carcinoma in situ (LCIS).
*These entities (ALH, LCIS) are near identical from a histomorphologic perspective.
*The difference is extent of involvement:
**ALH <50% of terminal duct lobular unit (TDLU) is involved.
**LCIS >=50% of TDLU is involved.
==Atypical lobular hyperplasia==
*Abbreviated ''ALH''.
===Microscopic===
See ''LCIS''.


==Lobular carcinoma in situ==
==Lobular carcinoma in situ==
*Abbreviated ''LCIS''.
*Abbreviated ''LCIS''.
===General===
*Management is currently some matter of debate.
*Management is currently some matter of debate.
*Not detected radiologically - it is an incidental pathologic finding.
*Not detected radiologically - it is an incidental pathologic finding.


==See also==
===Microscopic===
Features:<ref name=Ref_TPoSP188>{{Ref TPoSP|188}}</ref><ref name=Ref_BP170>{{Ref BP|170}}</ref>
*Cells distend the duct.
*Dyscohesive - distinct cell border visible.
*Clear cytoplasm (focally); may have signet ring cell-like appearance.
*Eccentrically placed round nucleus,
**Usually minimal atypia, relatively small ~1-2x size lymphocyte.
**+/-Nucleolus.
 
====Subclassification<ref name=Ref_BP170>{{Ref BP|170}}</ref>====
*Non-PLCIS.
**Type A.
***Nucleus 1-1.5x lymphocyte.
***No nucleolus.
**Type B.
***Nucleus ~2x lymphocyte.
***Nucleolus present.
*PLCIS (pleomorphic lobular carcinoma in situ).
 
Main DDx:
*Low-grade DCIS.
 
=See also=
*[[Breast]].
*[[Breast]].
*[[Invasive breast cancer]].
*[[Invasive breast cancer]].


==References==
=References=
{{reflist|2}}
{{reflist|2}}


[[Category:Breast pathology]]
[[Category:Breast pathology]]